:

Bor-Shiuan Shyr1,2, Ting-Chung Chen1,2, Shin-E Wang1,2

  • 1Division of General Surgery, Department of Surgery and Therapeutic and Research Center of Pancreatic Cancer Taipei Veterans General Hospital Taipei Taiwan (ROC).

Health science reports
|April 14, 2025
PubMed
概括

与胰腺管腺癌 (PDAC) 相比,胰腺酸性细胞癌 (PACC) 的淋巴结参与和入侵率较低. 然而,在匹配后,可切除的PACC和PDAC之间的生存结果是相似的.

相关概念视频